| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Zentalis Pharmaceuticals, Inc. | - | 5.1% | EDGAR |
| SC 13G/A | 2024-02-13 | Avidity Partners Management LP | Zentalis Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Zentalis Pharmaceuticals, Inc. | 5,350,458 | 7.6% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Zentalis Pharmaceuticals, Inc. | 10,336,971 | 14.6% | EDGAR |
| SC 13G/A | 2024-02-09 | WELLINGTON MANAGEMENT GROUP LLP | Zentalis Pharmaceuticals, Inc. | 68,791 | 0.1% | EDGAR |
| SC 13G/A | 2024-02-09 | Capital International Investors | Zentalis Pharmaceuticals, Inc. | 2,819,664 | 4.0% | EDGAR |
| SC 13G/A | 2024-01-29 | BlackRock Inc. | Zentalis Pharmaceuticals, Inc. | 4,684,975 | 6.6% | EDGAR |
| SC 13G/A | 2024-01-25 | STATE STREET CORP | Zentalis Pharmaceuticals, Inc. | - | 6.2% | EDGAR |
| SC 13G/A | 2023-12-11 | EVENTIDE ASSET MANAGEMENT, LLC | Zentalis Pharmaceuticals, Inc. | 11,559,975 | 16.3% | EDGAR |
| SC 13G | 2023-11-17 | CITADEL ADVISORS LLC | Zentalis Pharmaceuticals, Inc. | - | 5.1% | EDGAR |
| SC 13G | 2023-10-10 | EVENTIDE ASSET MANAGEMENT, LLC | Zentalis Pharmaceuticals, Inc. | 7,814,039 | 11.1% | EDGAR |
| SC 13D/A | 2023-06-20 | Matrix Capital Management Company, LP | Zentalis Pharmaceuticals, Inc. | 13,959,973 | 19.8% | EDGAR |
| SC 13G/A | 2023-03-10 | SUN ANTHONY Y | Zentalis Pharmaceuticals, Inc. | 360,542 | 0.6% | EDGAR |
| SC 13G/A | 2023-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Zentalis Pharmaceuticals, Inc. | 2,176,700 | 3.8% | EDGAR |
| SC 13G/A | 2023-02-14 | Avidity Partners Management LP | Zentalis Pharmaceuticals, Inc. | 5,150,000 | 9.0% | EDGAR |
| SC 13G | 2023-02-14 | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | Zentalis Pharmaceuticals, Inc. | 2,231,427 | 3.9% | EDGAR |
| SC 13G | 2023-02-13 | Capital International Investors | Zentalis Pharmaceuticals, Inc. | 3,048,182 | 5.3% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Zentalis Pharmaceuticals, Inc. | 7,909,176 | 13.9% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Zentalis Pharmaceuticals, Inc. | 4,160,149 | 7.3% | EDGAR |
| SC 13G | 2023-02-07 | STATE STREET CORP | Zentalis Pharmaceuticals, Inc. | - | 5.4% | EDGAR |